1. Home
  2. TTSH vs DCTH Comparison

TTSH vs DCTH Comparison

Compare TTSH & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tile Shop Holdings Inc.

TTSH

Tile Shop Holdings Inc.

HOLD

Current Price

$3.58

Market Cap

279.3M

Sector

Finance

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.20

Market Cap

350.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTSH
DCTH
Founded
1985
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.3M
350.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TTSH
DCTH
Price
$3.58
$10.20
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$22.60
AVG Volume (30 Days)
848.3K
527.6K
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$338,787,000.00
$79,603,000.00
Revenue This Year
N/A
$131.69
Revenue Next Year
N/A
$39.22
P/E Ratio
N/A
$299.08
Revenue Growth
N/A
251.54
52 Week Low
$3.56
$8.12
52 Week High
$7.75
$18.23

Technical Indicators

Market Signals
Indicator
TTSH
DCTH
Relative Strength Index (RSI) 13.70 58.13
Support Level $3.56 $9.92
Resistance Level $4.35 $10.40
Average True Range (ATR) 0.49 0.41
MACD -0.30 0.02
Stochastic Oscillator 1.41 57.55

Price Performance

Historical Comparison
TTSH
DCTH

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: